tradingkey.logo
tradingkey.logo

Rockwell Medical Inc

RMTI
View Detailed Chart
0.859USD
-0.083-8.83%
Market hours ETQuotes delayed by 15 min
1.62MMarket Cap
LossP/E TTM

Rockwell Medical Inc

0.859
-0.083-8.83%
Intraday
1m
30m
1h
D
W
M
D

Today

-8.83%

5 Days

-18.20%

1 Month

-4.63%

6 Months

-32.37%

Year to Date

+3.05%

1 Year

-24.66%

View Detailed Chart

TradingKey Stock Score of Rockwell Medical Inc

Currency: USD Updated: 2026-03-27

Key Insights

Rockwell Medical Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 85 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.50.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Rockwell Medical Inc's Score

Industry at a Glance

Industry Ranking
85 / 157
Overall Ranking
221 / 4542
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Rockwell Medical Inc Highlights

StrengthsRisks
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Growing
The company is in a growing phase, with the latest annual income totaling USD 69.26M.
Fairly Valued
The company’s latest PE is -5.89, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 3.38M shares, decreasing 53.15% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.40M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.92.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
3.250
Target Price
+244.97%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Rockwell Medical Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Rockwell Medical Inc Info

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Ticker SymbolRMTI
CompanyRockwell Medical Inc
CEOStrobeck (Mark)
Websitehttps://www.rockwellmed.com/
KeyAI